The Clinical and Laboratory Standards Institute has published Standard reference guidelines for susceptibility testing of yeasts M27-A3. 4, 5 This document provides data based interpretive breakpoints for testing the susceptibility of Candida species to fluconazole, itraconazole, voriconazole, flucytosine, and the echinocandins. 3, 4 Hence, this study was undertaken for detecting resistant strains causing candidemia using E-Strip by estimating their Minimum Inhibitory Concentration (MIC).This will help to provide prompt & effective antifungal therapy to the patients.
METHODS
The study was done at Sri Ramachandra Medical College and Research Institute, Chennai which is a tertiary care centre. It is a retrospective hospital based descriptive study.
Around 70 yeast isolates which grew from blood cultures were considered for this study. They were speciated using conventional phenotypic methods like gram stain, germ tube production, growth on TTZ( Tetrazolium reduction medium) and sugar fermentation and assimilation studies. Candida albicans ATCC 90028, Candida parapsilosis ATCC 22019 and Candida krusei ATCC 6258 were quality controls used for all antifungal agents, each time antifungal susceptibility test was performed.
E test method
MIC of the isolates were determined by using agar based E test method using Mueller-Hinton agar supplemented with 2% glucose and 0.5% µg/ml methylene blue (MH-GMB). This media is already proven to work well for determining the MIC of azoles by E test. 6 MH-GMB agar plates were inoculated by dipping a sterile swab into the inoculum suspension( adjusted to 0.5 McFarland standard i.e. 10 6 cells/ml) and streaking it along the agar surface in four directions to spread it as a lawn culture . The agar plates were then dried for sometime before applying the E test strips. The plates were then incubated at 35 0 C for 24 -48 hours or until visible growth was seen. The MIC value was read at the point of intersection between the zone edge and the E-test strip, if the end point was clear. When growth occurs along the entire strip i.e. no inhibition ellipse is seen, the MIC was reported as more than the highest value on the MIC scale. When the inhibition ellipse was below the strip i.e. the zone edge did not intersect the strip, the MIC was reported to be less than the lowest value on the MIC scale. 7 The organisms were categorized into susceptible (S), susceptible dose dependant (SDD) and resistant (R) based on the MIC reading. For azoles, significant inhibition, 80% decrease in growth density is required to visually select the end point. 8 Interpretation was done as per CLSI M27-A3 document guidelines. MIC50 and MIC90 (the MIC at which 50% and 90% of the isolates are inhibited) were also calculated.
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RESULTS
A total of 70 Candida spp isolated from blood were used for this study. C. albicans (39%) was the most common species isolated followed by C. tropicalis (33%), C. parapsilosis (11%), C. krusei(4%), C .glabrata(3%) and other Candida sp (10%) ( Table 1) . 
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Total samples 70 The MIC 90 for Candida albicans, Candida tropicalis was found to be 0.25 µg/ml and for Candida paropsilosis, Candida krusei and Candida glabrata were 0.047µg/ml, 0.19µg/ml and 0.125µg/ml respectively. None of the Candida sp isolated were resistant to voriconazole, whereas Candida albicans had a resistance percentage of 3.7%.
Ketoconazole:
The MIC 90 for, Candida tropicalis, Candida parapsilosis and Candida krusei was 0.19 µg/ml whereas for Candida albicans and Candida glabrata were (0.50 and 2) µg/ml. None of them showed resistance to ketoconazole.
Itraconazole:
The MIC90 for Candida glabrata was >32µg/ml with all the strains showing resistance to itraconazole (100%). The MIC90 values for Candida albicans, Candida krusei was found to be 0.50µg/ml and for Candida tropicalis, Candida parapsilosis it was found to be 0.38 and 0.75 µg/ml. None of the Candida tropicalis or Candida krusei were found to be resistant to itraconazole, whereas Candida albicans, Candida parapsilosis showed a minimum resistance of 7.4%, 12.5% respectively. 10 The rise may be attributed to the increased use of azoles. 11 This study was undertaken in view of recent increase in non-albicans Candida species causing blood stream infections and the changing pattern of their antifungal susceptibility profile.
In this study, the antifungal susceptibility testing was performed using agar based E test method (MH GMB), as there are few reports about the effectiveness of this method 6 and good agreement between the E-test and the broth micro-dilution method. 6, 12 In our study the majority of the isolates were found to be Candida albicans (39%), the next most common isolate was Candida tropicalis (33%) followed by Candida parapsilosis (11%). In previous studies Candida parapsilosis was next to Candida, 10, 13 whereas in few Indian studies Candida tropicalis was the most common species isolated followed by Candida albicans. 14, 15 The distribution of the species is different in various regions and studies. Our data also suggested that non-albicans Candida (61%) was the predominant species when compared to Candida albicans (39%), which establishes the importance of non-albicans Candida in causing blood stream infections. This increase may be attributed to intensive, long term use of antifungals which may in turn contribute to their high level resistance. [16] [17] [18] Susceptibility of Candida albicans to fluconazole in this study was 88.9% (MIC 90 < 4µg/ml) comparable with susceptibility pattern of other studies( 79, 87.5). 20, 21 Candida albicans , Candida tropicalis and Candida parapsilosis had decreased resistance to azoles when compared to other Candida sp. Different rates of resistance were detected in different non albicans Candida sp. 22, 23 Candida krusei and Candida glabrata had increased resistance to fluconazole (66.7 and 100%) with MIC 90 >256 µg/ml. Candida glabrata had increased resistance to both fluconazole and Itraconazole (100%). From the perspective of antifungal resistance, Candida glabrata and Candida krusei are clearly the Candida species with the greatest potential to acquire resistance to fluconazole and Itraconazole. 22, 24 All the Candida species exhibited a very good activity against voriconazole except for one isolate of Candida albicans (resistance of 3.7%). Voriconazole was found to be an effective azole among all the Candida isolates tested, with the MIC90 being ≤ 0.25µg/ml. Susceptibility of voriconazole was similar to that seen in other surveillance studies done by Hoda et al.; Marshall lyon et al. and Madhavan et al. 10, 25, 26 Though ketoconazole also had a very good activity against Candida species they can be used to treat only mucocutaneous infections.
Interestingly in our study, isolates of Candida exhibiting resistance to fluconazole and itraconazole were sensitive to voriconazole which proves it as an effective azole. These findings implies that voriconazole, due to its wider species coverage, can be used in the treatment of candidemia caused by fluconazole resistant strains. This was also confirmed in the previous studies done by Madhavan et al. (2010) and Hoda et al (2009) . 26, 10 Due to the increase in resistant non albicans Candida sp causing blood stream infections, it is mandatory to know the antifungal susceptibility pattern of commonly available antifungal agents for effective management of patients. Though newer antifungal agents are available and effective, they are very expensive and may not be affordable for all patients.
The findings of the in-vitro resistance pattern of the different Candida species implies that antifungal susceptibility should be carried out routinely for all invasive infections caused by Candida species to detect the emergence of antifungal resistance.
